BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35043376)

  • 1. Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.
    Wu P; Dong Y; Chen J; Guan T; Cao B; Zhang Y; Qi Y; Guan Z; Wang Y
    Neurotox Res; 2022 Feb; 40(1):286-297. PubMed ID: 35043376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity.
    Wang Y; Chen C; Huang W; Huang M; Wang J; Chen X; Ye Q
    Aging (Albany NY); 2019 Oct; 11(20):8937-8950. PubMed ID: 31634150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
    Jhuo CF; Chen CJ; Tzen JTC; Chen WY
    Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.
    Clark J; Silvaggi JM; Kiselak T; Zheng K; Clore EL; Dai Y; Bass CE; Simon DK
    PLoS One; 2012; 7(11):e48925. PubMed ID: 23145024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Mudò G; Mäkelä J; Di Liberto V; Tselykh TV; Olivieri M; Piepponen P; Eriksson O; Mälkiä A; Bonomo A; Kairisalo M; Aguirre JA; Korhonen L; Belluardo N; Lindholm D
    Cell Mol Life Sci; 2012 Apr; 69(7):1153-65. PubMed ID: 21984601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1α-siRNA suppresses inflammation in substantia nigra of PD mice by inhibiting microglia.
    Guan X; Wu P; Cao B; Liu X; Chen X; Zhang W; Zhang Y; Guan Z; Wang Y
    Int J Neurosci; 2023 Mar; 133(3):269-277. PubMed ID: 33784949
    [No Abstract]   [Full Text] [Related]  

  • 7. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of neuroprotection by carnosic acid.
    Lin CY; Huang YN; Fu RH; Liao YH; Kuo TY; Tsai CW
    Phytomedicine; 2021 Jan; 80():153369. PubMed ID: 33070082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interaction of Mitochondrial Biogenesis and Fission/Fusion Mediated by PGC-1α Regulates Rotenone-Induced Dopaminergic Neurotoxicity.
    Peng K; Yang L; Wang J; Ye F; Dan G; Zhao Y; Cai Y; Cui Z; Ao L; Liu J; Zou Z; Sai Y; Cao J
    Mol Neurobiol; 2017 Jul; 54(5):3783-3797. PubMed ID: 27271125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
    Zhang L; Zhang L; Li Y; Li L; Melchiorsen JU; Rosenkilde M; Hölscher C
    J Parkinsons Dis; 2020; 10(2):523-542. PubMed ID: 31958096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease.
    Das NR; Vaidya B; Khare P; Bishnoi M; Sharma SS
    Curr Neurovasc Res; 2021; 18(5):497-507. PubMed ID: 34923943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
    Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
    Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection.
    Kang H; Khang R; Ham S; Jeong GR; Kim H; Jo M; Lee BD; Lee YI; Jo A; Park C; Kim H; Seo J; Paek SH; Lee YS; Choi JY; Lee Y; Shin JH
    Oncotarget; 2017 Jul; 8(30):48603-48618. PubMed ID: 28611284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Lipoic Acid Attenuates MPTP/MPP
    Zhang J; Gao Y; Zhang L; Zhang C; Zhao Y; Zhang Y; Li S; Chang C; Zhang X; Yang G
    Neurotox Res; 2022 Apr; 40(2):410-419. PubMed ID: 35146598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.
    Hasegawa K; Yasuda T; Shiraishi C; Fujiwara K; Przedborski S; Mochizuki H; Yoshikawa K
    Nat Commun; 2016 Mar; 7():10943. PubMed ID: 26971449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
    Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z; Li D; Feng P; Xue G; Ji C; Li G; Hölscher C
    Eur J Pharmacol; 2017 Oct; 812():82-90. PubMed ID: 28666800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.
    Zhang X; Ren X; Zhang Q; Li Z; Ma S; Bao J; Li Z; Bai X; Zheng L; Zhang Z; Shang S; Zhang C; Wang C; Cao L; Wang Q; Ji J
    Antioxid Redox Signal; 2016 Feb; 24(6):312-28. PubMed ID: 26421366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease.
    Joniec-Maciejak I; Wawer A; Turzyńska D; Sobolewska A; Maciejak P; Szyndler J; Mirowska-Guzel D; Płaźnik A
    Pharmacol Rep; 2018 Oct; 70(5):988-992. PubMed ID: 30107349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.
    Xi Y; Feng D; Tao K; Wang R; Shi Y; Qin H; Murphy MP; Yang Q; Zhao G
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2859-2870. PubMed ID: 29842922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.